Safety of the 2D/3D direct acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - a pooled analysis

Chronic hepatitis C virus (HCV) infection is characterized by progressive liver damage and fibrosis, which can lead to liver failure or hepatocellular carcinoma [1]. In 2013, an estimated 357,800 people worldwide died from HCV-related cirrhosis, and an additional 342,500 people died from liver cancer caused by HCV [2]. The burden of HCV-associated liver disease is projected to continue to increase in many countries in the coming decades [3].

Source: Journal of Hepatology - June 20, 2017 Category: Gastroenterology Authors: Fred Poordad, David R. Nelson, Jordan J. Feld, Michael W. Fried, Heiner Wedemeyer, Lois Larsen, Daniel E. Cohen, Eric Cohen, Niloufar Mobashery, Fernando Tatsch, Graham R. Foster Source Type: research